Sucharita Ray

Addl Professor Neurology, PGIMER, Former Stroke Fellow Calgary.

[Sucharita Ray @Atirahcus]

Primary care physicians need more familiarity with ICHD-3 classification system and training on initiating prophylactic therapy in migraine. Use of analgesics, supplements striking. More infor on the primary care headache scenario on our article

https://t.co/NTcMPFwx0R

[Stroke AHA/ASA @StrokeAHA_ASA]

🧵 Focused Update: Inflammation in Intracranial Aneurysms in #Stroke 🎈 Pathogen pattern recognition receptors activated by PAMPs and DAMPs drive inflammatory responses that contribute to aneurysm formation, progression, and rupture, as well as brain injury after aSAH.

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE: In a multicenter cohort of patients with acute mild basilar artery occlusion (NIHSS<10), EVT was linked to better 90-day functional independence vs. BMT, but carried a higher risk of symptomatic ICH, with no mortality difference. #AHAJournals https://t.co/hVB6MhDsOn

[JAMA Neurology @JAMANeuro]

Among patients with multiple sclerosis treated long-term with ocrelizumab, interstitial lung disease developed after a mean of 10.5 years, mainly as organizing pneumonia with variable outcomes; prompt recognition and corticosteroid treatment are important. https://t.co/fqeJphg1X6

[Sucharita Ray @Atirahcus]

Stroke research is probably one of the most crucial fields evolving with the concept of pragmatic trials. Happy to be a part of the research with Ayo, Prof Sajobi , @bijoymenon and team from @DCNSNeuro

https://t.co/F8jvqIBDzF

[Isaac Lamb, MD @IsaacLamb01]

There are many excellent radiology resources to help with NPH imaging. @teachplaygrub has done several threads, and this @Radiopaedia article is another resource I frequently reference.

https://t.co/J12r2Mr7Q7

https://t.co/2H8D7aeP07

[Isaac Lamb, MD @IsaacLamb01]

NORMAL PRESSURE HYDROCEPHALUS

NPH is one of the more controversial diagnoses in neurology. Depending on who you ask, it’s vastly overdiagnosed, underdiagnosed, or even nonexistent. Here’s a thread on diagnosis, imaging, and management.

[脳神経外科医 堀 聡 Satoshi Hori @2aTkg86WMYicOGs]

非手術例の慢性硬膜下血腫に対し、MMA塞栓単独と保存的治療を比較、MMA塞栓が5年後の認知症発症を有意に減少

認知症は神経心理学検査で評価したわけでなく、データベースから認知症と診断された症例であること、症例の生活背景の考慮がないなど、だいぶ疑問。さすがに過剰治療介入では

STROKEだが

[Sucharita Ray @Atirahcus]

@PeterItebimien @daoo100 @albertoortegana @IhabFathiSulima @memwwnz @elidyynwa @nirmalregency @aditya_gan3500 @studyrare @docakx @drkeithsiau Interesting case, does the same thing happen when doing some activity with the non dominant hand ?

[Sucharita Ray @Atirahcus]

@ANRFIndia where can I get the list of projects approved last year ? I wanted to go through it for guidance.

[Yiran Zhang @Renny_yr]

Day 1 Trial Summary of #ESOC26 @CSC_Stroke @neuromaheshkate

[Sucharita Ray @Atirahcus]

He hasn’t talked to me ever since and we just went with that design as it was approved keeping in mind his services that we were retaining.

Mediocrity is the new brilliant.

On hindsight @AbhinavAgarwal sir, if Godrej is paying such guys to stay afloat, why shld I be whining ?

[Sucharita Ray @Atirahcus]

Ditto when I confronted a software designer for his logo design 4 @ictrims2024 I was helping organizing.

The brain on the logo was literally the 1st image tht came up on searching brain on Shutterstock.

He told me it takes effort to even copy paste from the net. 🙏

[Abhinav Agarwal @AbhinavAgarwal]

On top is Godrej's old logo.
Since 1897.
Recognized across India.

At the bottom is the new, redesigned logo, designed by Disco, Godrej’s in-house design studio.

The second image is the logo for Guerrilla Holdings, an Australian company.

If incompetence ever needed a logo.

[Abhinav Agarwal @AbhinavAgarwal]

On top is Godrej's old logo.
Since 1897.
Recognized across India.

At the bottom is the new, redesigned logo, designed by Disco, Godrej’s in-house design studio.

The second image is the logo for Guerrilla Holdings, an Australian company.

If incompetence ever needed a logo.

[Abhishek Lenka @AbhiLenka11]

After nearly 14 years as a student of neurosciences (PhD → residency → fellowship → faculty), I found myself wondering why I’d never thought/read beyond alpha-synuclein. What about beta and gamma; do they even exist (they should!)?

So, on a random Sunday afternoon (while preparing slides for a talk), curiosity got the better of me. Turns out they not only exist but also have meaningful clinical relevance: β-synuclein may be a marker of cognitive impairment, while γ-synuclein was first identified as a breast cancer–associated gene (may be a marker of some aggressive tumors)!

[Nice editorial on 👇Beta-synuclein as a biomarker of neurodegenerative dementia. Link to the original study: https://t.co/ZaVwMqEqxB]

[Bishal Gyawali, MD, PhD, FASCO @oncology_bg]

It’s strange that we ask trainees to read clinical trials but never really teach them how to read clinical trials.
I’d request all training program directors and mentors to please share this article to their trainees and fellows- https://t.co/HJhZlsAS4u

Grateful to @JCOOP_ASCO for making this free.

[Sucharita Ray @Atirahcus]

@AlJerdi @NEJM @neurointensivos We institute this all the time. IV metoprolol cannot reduce blood pressures in a chunk of cases and simultaneous administration of other antihypertensives has always come to the rescue.

So amazing now because of a trial people will start talking about it !

[Sucharita Ray @Atirahcus]

Technically this is common practice in India.

But it’s amazing to see this conducted and published as a successful trial for neurologists to accept it.

[NEJM @NEJM]

Among survivors of intracerebral hemorrhage, a single pill with three low-dose antihypertensive agents added to standard care was associated with a lower incidence of stroke and major cardiovascular events than placebo. Full TRIDENT trial results: https://t.co/0tiij1H7tb

Editorial: Blood-Pressure Control after Intracerebral Hemorrhage — An Unbroken Glass Ceiling https://t.co/Me1YWely2x

[Sucharita Ray @Atirahcus]

@NostalgicHubb @UtdFanChika A Man

[Jessica Rudnay @StrokeConsJER]

Doesn’t marry up with ENRICH-AF halting recruitment to the lobar haemorrhage arm… Eagerly awaiting the results.